
Combine the potential of stem cell therapy with nanotechnology
MICA’s cell therapy uses ground-breaking advances in nanotechnology to revolutionise the field of regenerative medicine; truly unlocking the potential of stem cells to treat anything from spinal injuries and diseases, to tendon damage, neurodegenerative diseases and oncology. Remote-controlled stem cells are here!
It can also be used for drug screening by inducing a dynamic environment for drug screening through our patented Dynascreen™ platform. Further capitalising on the possibilities of nanotechnology, we have developed a bioreactor capable of growing cells and organoids in a dynamic, mechanically stimulated environment to open the window into scientific research around disease, development and discovery.
Our
Collaborators









Awards and Funding








Our Products
MICA Biosystems constitutes three platforms, each developed from our patented nanotechnology research.
Dynagrow™
We enable new approaches to tissue engineering, regenerative medicine, drug discovery, and therapy via novel magnetic ion channel activation.
Dynascreen™
Our patented drug screening platform establishes an industry-first standardised assay to assess drug absorption.
MICA Cell Therapy
MICA Cell Therapy has a wide-reaching potential to improve the lives of millions of people. Below are some of the therapy areas which could benefit from our technology.
"Our aim isn't purely to take our technology to clinic- we want to reinvigorate excitement around the endless potential for stem cells to revolutionise healthcare."
Michal Zurawski
CEO
Ready to find out more?
Should you decide that one of our platforms would be a valuable addition to your operations, our team of Business Associates are on on hand to provide you with additional material and can schedule a live demonstration with a member of our R&D team.